Kahn A - Search Results

1

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C. Colnot S, et al. Among authors: kahn a. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21. doi: 10.1073/pnas.0404761101. Epub 2004 Nov 24. Proc Natl Acad Sci U S A. 2004. PMID: 15563600 Free PMC article.

2

Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.

Andreu P, Colnot S, Godard C, Gad S, Chafey P, Niwa-Kawakita M, Laurent-Puig P, Kahn A, Robine S, Perret C, Romagnolo B. Andreu P, et al. Among authors: kahn a. Development. 2005 Mar;132(6):1443-51. doi: 10.1242/dev.01700. Epub 2005 Feb 16. Development. 2005. PMID: 15716339

3

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.

Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn A, Perret C, Colnot S. Benhamouche S, et al. Among authors: kahn a. Dev Cell. 2006 Jun;10(6):759-70. doi: 10.1016/j.devcel.2006.03.015. Dev Cell. 2006. PMID: 16740478 Free article.

4

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. de La Coste A, et al. Among authors: kahn a. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51. doi: 10.1073/pnas.95.15.8847. Proc Natl Acad Sci U S A. 1998. PMID: 9671767 Free PMC article.

5

New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.

Cadoret A, Ovejero C, Terris B, Souil E, Lévy L, Lamers WH, Kitajewski J, Kahn A, Perret C. Cadoret A, et al. Among authors: kahn a. Oncogene. 2002 Nov 28;21(54):8293-301. doi: 10.1038/sj.onc.1206118. Oncogene. 2002. PMID: 12447692

6

Identification of the IFITM family as a new molecular marker in human colorectal tumors.

Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, Perret C, Romagnolo B. Andreu P, et al. Among authors: kahn a. Cancer Res. 2006 Feb 15;66(4):1949-55. doi: 10.1158/0008-5472.CAN-05-2731. Cancer Res. 2006. PMID: 16488993

7

Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.

Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C. Romagnolo B, et al. Among authors: kahn a. Cancer Res. 1999 Aug 15;59(16):3875-9. Cancer Res. 1999. PMID: 10463573

8

Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.

Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C. Cadoret A, et al. Among authors: kahn a. Cancer Res. 2001 Apr 15;61(8):3245-9. Cancer Res. 2001. PMID: 11309273

9

Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.

Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A, Perret C. Saadi-Kheddouci S, et al. Among authors: kahn a. Oncogene. 2001 Sep 20;20(42):5972-81. doi: 10.1038/sj.onc.1204825. Oncogene. 2001. PMID: 11593404

10

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.

Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S. Lesbordes-Brion JC, et al. Among authors: kahn a. Blood. 2006 Aug 15;108(4):1402-5. doi: 10.1182/blood-2006-02-003376. Epub 2006 Mar 30. Blood. 2006. PMID: 16574947 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,828 results

Search Page

Filters